2Yang W, Lu J, China National Diabetes and Metabolic Disorders Study Group, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362: 1090-1101.
3Nawaaz Nathoo, ManCho Ng, Christopher J, et al. The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta. Can J Ophthalmol, 2010, 45: 28-32.
4Javadi MA, Katibeh M, Rafati N, et al. Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol, 2009, 9: 12.
5Dedov I, Maslova O, Suntsov Y, et al. Prevalence of diabetic retinopathy and cataract in adult patients with type 1 and type 2 diabetes in Russia. Rev Diabet Stud, 2009, 6 : 124-129.
6Esteves JF, Kramer CK, Azevedo MJ, et al. Prevalence of diabetic retinopathy in patients with type I diabetes mellitus. Rev Assoc Med Bras, 2009, 55 : 268-273.
7Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res, 2006, 69: 562-573.
8Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sei Signal, 2008, 1 : re6.
9Varani J, Perone P, Warner RL, et al. Vascular tube formation on matrix metalloproteinase-l-damaged collagen. BrJ Cancer, 2008, 98: 1646-1652.
10Miyata Y, Iwata T, Ohba K, , et al. Expression of matrix metalloproteinase-7 on cancer ceils and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res, 2006, 12: 6998-7003.
